1-2 of 2
valproic acid
Close
Sort by
Journal Articles

Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation

Luena Papa, Eran Zimran, Mansour Djedaini, Yongchao Ge, Umut Ozbek, Robert Sebra, Stuart C. Sealfon, Ronald Hoffman
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2766–2779.
https://doi.org/10.1182/bloodadvances.2018024273
Published: 2018
Includes: Supplemental data
Journal Articles

Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)

Clinical Trials & Observations
Kristina Drott, Hans Hagberg, Karin Papworth, Thomas Relander, Mats Jerkeman
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1386–1392.
https://doi.org/10.1182/bloodadvances.2018019240
Published: 2018
Includes: Supplemental data